Susquehanna International Group’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,450
Closed -$6.61K 12679
2025
Q1
$6.61K Buy
+1,450
New +$7.17K ﹤0.01% 12242
2024
Q1
Sell
-1,438
Closed -$14.4K 12195
2023
Q4
$14.4K Buy
+1,438
New +$10.9K ﹤0.01% 12024
2023
Q1
Sell
-2,988
Closed -$80.1K 12581
2022
Q4
$80.1K Buy
2,988
+513
+21% +$14.7K ﹤0.01% 11124
2022
Q3
$78K Buy
+2,475
New +$64.1K ﹤0.01% 11905
2022
Q2
Sell
-12,463
Closed -$446K 12911
2022
Q1
$446K Sell
12,463
-4,875
-28% -$162K ﹤0.01% 9262
2021
Q4
$540K Buy
17,338
+12,275
+242% +$473K ﹤0.01% 8981
2021
Q3
$182K Buy
5,063
+1,450
+40% +$47.7K ﹤0.01% 11602
2021
Q2
$116K Sell
3,613
-1,100
-23% -$37.3K ﹤0.01% 12013
2021
Q1
$206K Buy
+4,713
New +$242K ﹤0.01% 11368
2020
Q4
Sell
-1,413
Closed -$78K 11013
2020
Q3
$78K Buy
+1,413
New +$91.4K ﹤0.01% 10044

Other funds holding BMRA

Susquehanna International Group's BMRA Position: Q2 2025 in Review

Susquehanna International Group sold out of Biomerica (BMRA) in Q2 2025, closing a stake of 1,566 shares — an estimated $5.57K sold.

Susquehanna International Group first reported a position in BMRA in Q2 2018 and held it in 18 quarters. The position peaked at $332K in Q3 2022. 12 funds tracked by Wall St. Rank hold BMRA as of Q2 2025.

  • Susquehanna International Group reported no remaining Biomerica position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 1,566 Biomerica shares in Q2 2025, an estimated $5.57K.
  • Susquehanna International Group first reported a position in Biomerica in Q2 2018 and held it in 18 quarters.
  • Susquehanna International Group's Biomerica position peaked at $332K in Q3 2022.
  • 12 funds tracked by Wall St. Rank held Biomerica as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.